On ECHEMI
Home > Drugs > Hainan Bikai Pharmaceutical Co., Ltd.
Hainan Bikai Pharmaceutical Co., Ltd.
  • Founded in:

    1993-03-22
  • Country:

    China China
  • Address:

    No. 10, Yaogu 1st Road, Haikou National High-tech Industrial Development Zone, Hainan Province
  • Tax NO.:

    91460100284031692C
  • Registered Funds:

    20 million yuan
  • Website:

  • Email:

Related Drugs
Carvedilol
Name Description Content CAS NO. Registered Holders
Carvedilol

Extract from the above information

More

Extract from the above information

72956-09-3 51
Carvedilol Tablets
The main ingredient of this product is carvedilol.
Name Description Content CAS NO. Registered Holders
Carvedilol

Within the therapeutic dose range, it has both (1) and non-selective (2) receptor blocking effects, and has no intrinsic sympathomimetic activity. It blocks the (1) receptors on the postsynaptic membrane, thereby dilating blood vessels and reducing peripheral vascular resistance; it blocks the (2) receptors, inhibits the secretion of renin by the kidneys, blocks the renin-angiotensin-aldosterone system, and produces a hypotensive effect. Carvedilol lowers blood pressure rapidly and can maintain its hypotensive effect for a long time. It has no effect on left ventricular ejection fraction, cardiac function, renal function, renal blood perfusion, peripheral blood flow, plasma electrolytes and blood lipid levels, does not affect heart rate or slightly slows it down, and rarely produces water and sodium retention.

More

Within the therapeutic dose range, it has both (1) and non-selective (2) receptor blocking effects, and has no intrinsic sympathomimetic activity. It blocks the (1) receptors on the postsynaptic membrane, thereby dilating blood vessels and reducing peripheral vascular resistance; it blocks the (2) receptors, inhibits the secretion of renin by the kidneys, blocks the renin-angiotensin-aldosterone system, and produces a hypotensive effect. Carvedilol lowers blood pressure rapidly and can maintain its hypotensive effect for a long time. It has no effect on left ventricular ejection fraction, cardiac function, renal function, renal blood perfusion, peripheral blood flow, plasma electrolytes and blood lipid levels, does not affect heart rate or slightly slows it down, and rarely produces water and sodium retention.

72956-09-3 51
Alprostadil Injection
The main ingredient of this product is prostaglandin E1, its chemical name: (1R, 2R, 3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxy-1-octenyl]-5-oxocyclopentaneheptanoic acid Molecular formula: C20H34O5 Molecular weight: 354.49 Excipients: soybean oil (for injection), lecithin (for injection), glycerol (for injection), oleic acid, sodium hydroxide, water for injection.
Name Description Content CAS NO. Registered Holders
Prostaglandin E1

Dilate blood vessels, inhibit platelet aggregation; stabilize liver cell membranes and improve liver function

More

Dilate blood vessels, inhibit platelet aggregation; stabilize liver cell membranes and improve liver function

745-65-3 14
Tetracaine Hydrochloride for Injection
The main ingredient of this product is tetracaine hydrochloride, and its chemical name is 4-(butylamino)-benzoic acid-2-(dimethylamino)ethyl ester hydrochloride.
Name Description Content CAS NO. Registered Holders
Tetracaine hydrochloride

After entering the blood, most of this product binds to plasma proteins and accumulates in tissues, with the largest accumulation in skeletal muscle. When the concentration in plasma decreases, it is released again. Most of this product is hydrolyzed and converted by plasma cholinesterase, metabolized by the liver into p-aminobenzoic acid and dimethylaminoethanol, and then degraded or combined and excreted in the urine.

More

After entering the blood, most of this product binds to plasma proteins and accumulates in tissues, with the largest accumulation in skeletal muscle. When the concentration in plasma decreases, it is released again. Most of this product is hydrolyzed and converted by plasma cholinesterase, metabolized by the liver into p-aminobenzoic acid and dimethylaminoethanol, and then degraded or combined and excreted in the urine.

136-47-0 16
Clotrimazole vaginal tablets
Each tablet of this product contains 0.5g of clotrimazole, the main ingredient. The auxiliary materials are lactose, microcrystalline cellulose, calcium lactate, hypromellose, lactic acid, micro-powder silica gel, cross-linked polyvinylpyrrolidone, and magnesium stearate.
Name Description Content CAS NO. Registered Holders
Clotrimazole

This product is a broad-spectrum antifungal drug with good antibacterial effect on many fungi, especially Candida albicans. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic process.

More

This product is a broad-spectrum antifungal drug with good antibacterial effect on many fungi, especially Candida albicans. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic process.

0.5g 23593-75-1 45
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.